News
Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed ...
State Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, China University of Chinese Academy of Sciences, Beijing 100190, China ...
Millions of Australian women have long suffered in silence, but that could all be about to change.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results